300 KRW
21.26 B KRW
388.79 B KRW
18.41 M
About CELLTRION PHARM INC.
Sector
CEO
Jeong-Su Seo
Headquarters
Cheongju
Website
Founded
2000
ISIN
KR7068760008
FIGI
BBG000L3WRG7
Celltrion Pharm, Inc. engages in the manufacture and sale of pharmaceuticals. Its products are categorized into the following: the group of medicine effect, biosimilars and over-the-counter (OTC) drug. The group of medicine effect includes hepatotonics, hepatotonics and anti-inflammatory drugs, antihistamine, respiratory apparatus drugs, circulatory system drug, digestives and stomachics drug, hormone and metabolic disease drugs, antibiotics and antimycotic, nutrientia and tonic, immunology, oncology, and the other drugs. The products of OTC drugs include alcetin tab, alchipil tab, anola tab, araphen tab, ascit granule, caldip tab, celltrion aceclofenac tab, celltrion atenolol tab, celltrion cefadroxil cap, celltrion diclofenac inj, celltrion domperidone tab, celltrion famotidine tab, and ceparo cap. The company was founded on November 17, 2000 and is headquartered in Cheongju, South Korea.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 068760 is 61,300 KRW — it has decreased by −0.33% in the past 24 hours. Watch CELLTRION PHARM INC. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on KRX exchange CELLTRION PHARM INC. stocks are traded under the ticker 068760.
068760 stock has fallen by −1.45% compared to the previous week, the month change is a −10.64% fall, over the last year CELLTRION PHARM INC. has showed a −10.60% decrease.
068760 reached its all-time high on Dec 28, 2020 with the price of 236,700 KRW, and its all-time low was 3,000 KRW and was reached on Dec 8, 2008. View more price dynamics on 068760 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
068760 stock is 2.94% volatile and has beta coefficient of 0.80. Track CELLTRION PHARM INC. stock price on the chart and check out the list of the most volatile stocks — is CELLTRION PHARM INC. there?
Yes, you can track CELLTRION PHARM INC. financials in yearly and quarterly reports right on TradingView.
068760 net income for the last quarter is 5.59 B KRW, while the quarter before that showed 1.89 B KRW of net income which accounts for 195.70% change. Track more CELLTRION PHARM INC. financial stats to get the full picture.
No, 068760 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 10, 2024, the company has 909.00 employees. See our rating of the largest employees — is CELLTRION PHARM INC. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CELLTRION PHARM INC. EBITDA is 45.43 B KRW, and current EBITDA margin is 14.34%. See more stats in CELLTRION PHARM INC. financial statements.
Like other stocks, 068760 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CELLTRION PHARM INC. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CELLTRION PHARM INC. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CELLTRION PHARM INC. stock shows the sell signal. See more of CELLTRION PHARM INC. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.